Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
04 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/04/2973907/8790/en/TG-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Raises-BRIUMVI-ublituximab-xiiy-Full-Year-Revenue-Guidance.html
01 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/01/2973327/8790/en/TG-Therapeutics-to-Host-Conference-Call-on-Third-Quarter-2024-Financial-Results-and-Business-Update.html
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948100/8790/en/New-BRIUMVI-ublituximab-xiiy-Data-from-the-ENHANCE-Phase-3b-Study-Show-Rapid-30-Minute-Infusions-are-Well-Tolerated-in-Patients-with-Relapsing-Forms-of-Multiple-Sclerosis.html
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948071/8790/en/New-Data-for-BRIUMVI-ublituximab-xiiy-Demonstrate-that-92-of-Patients-with-Relapsing-Multiple-Sclerosis-Were-Free-from-Disability-Progression-After-5-Years-of-Treatment.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941238/8790/en/TG-Therapeutics-Announces-Schedule-of-Data-Presentations-for-BRIUMVI-at-the-2024-European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Annual-Meeting.html
09 Aug 2024
// BUSINESSWIRE
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?